The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $53.48

Today's change+0.59 +1.12%
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $53.48

Today's change+0.59 +1.12%
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.

AbbVie Inc up (U.S.)$0.59

AbbVie Inc closed up Tuesday by (U.S.)$0.59 or 1.12% to (U.S.)$53.48. Over the last five days, shares have lost 0.87% and are down 9.72% for the last year to date. This security has outperformed the S&P 500 by 5.90% during the last year.

Key company metrics

  • Open(U.S.) $52.31
  • Previous close(U.S.) $52.89
  • High(U.S.) $53.94
  • Low(U.S.) $52.06
  • Bid / Ask(U.S.) $53.07 / (U.S.) $53.80
  • YTD % change-9.72%
  • Volume7,655,796
  • Average volume (10-day)11,381,961
  • Average volume (1-month)10,363,499
  • Average volume (3-month)9,825,836
  • 52-week range(U.S.) $45.45 to (U.S.) $71.60
  • Beta--
  • Trailing P/E17.02×
  • P/E 1 year forward10.53×
  • Forward PEG0.57×
  • Indicated annual dividend(U.S.) $2.28
  • Dividend yield4.26%
  • Trailing EPS(U.S.) $3.14
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX2.02%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue6,4005,9445,4755,040
Total other revenue--------
Total revenue6,4005,9445,4755,040
Gross profit4,9254,8664,5594,098
Total cost of revenue1,4751,078916942
Total operating expense4,2874,0593,6233,353
Selling / general / administrative1,7371,4741,7031,354
Research & development1,0751,418981811
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0023246
Other operating expenses, total00----
Operating income2,1131,8851,8521,687
Interest income (expense), net non-operating---207-172-132
Gain (loss) on sale of assets--------
Other--------
Income before tax1,9241,6471,6781,396
Income after tax1,5171,2391,3661,022
Income tax, total407408312374
Net income1,5171,2391,3661,022
Total adjustments to net income--------
Net income before extra. items1,5171,2391,3661,022
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,5171,2391,3661,022
Inc. avail. to common incl. extra. items1,5171,2391,3661,022
Diluted net income1,5171,2391,3661,022
Dilution adjustment--------
Diluted weighted average shares1,6401,6641,6331,608
Diluted EPS excluding extraordinary itemsvalue per share0.930.740.840.64
Dividends per sharevalue per share0.510.510.510.51
Diluted normalized EPSvalue per share0.930.740.850.77